Plazomicin: an investigational therapy for the treatment of urinary tract infections. - Wikidata - wikimedia - TriplyDB

Plazomicin: an investigational therapy for the treatment of urinary tract infections.

Plazomicin: an investigational therapy for the treatment of urinary tract infections.

http://www.wikidata.org/entity/Q34673393

about

Endless Resistance. Endless Antibiotics?Antibiotics in the clinical pipeline at the end of 2015.Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Spec Plazomicin Activity against 346 Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli Urinary Isolates in Relation to Aminoglycoside-Modifying Enzymes.Treatment of extended-spectrum β-lactamase-producing (ESBLs) infections: what have we learned until now?Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant

P2860

Q28822179-CC28674B-250A-48B2-8823-676899157ACC Q30249262-F9649AF4-D176-47B3-B82D-28FDD16C1D61 Q37203715-216B1CDE-9C1A-41DF-8D99-C6D918BDA0C4 Q37612977-4C24C777-4A2D-49E9-A2B8-FA0CFBA70E64 Q58694612-1773059B-898F-42B7-ABBA-765071F0C041 Q58746821-2E3CF8CE-D57B-4E46-97DC-A54CD4BB299A

P2860

Plazomicin: an investigational therapy for the treatment of urinary tract infections.

http://www.wikidata.org/entity/Q34673393

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Plazomicin: an investigational therapy for the treatment of urinary tract infections.

@ast

Plazomicin: an investigational therapy for the treatment of urinary tract infections.

@en

Plazomicin: an investigational therapy for the treatment of urinary tract infections.

@nl

type

label

Plazomicin: an investigational therapy for the treatment of urinary tract infections.

@ast

Plazomicin: an investigational therapy for the treatment of urinary tract infections.

@en

Plazomicin: an investigational therapy for the treatment of urinary tract infections.

@nl

prefLabel

Plazomicin: an investigational therapy for the treatment of urinary tract infections.

@ast

Plazomicin: an investigational therapy for the treatment of urinary tract infections.

@en

Plazomicin: an investigational therapy for the treatment of urinary tract infections.

@nl

P1433

Q34673393-40C70AFF-0CFF-4384-8B79-92C1CC798A4B

P1476

Q34673393-F4873C40-9294-4484-A7F4-E5A1E3A092F6

P2093

Q34673393-C55B8BB1-B075-4D0E-B2A5-52ADBD5CB89F

P2860

Q34673393-04603BD9-6554-499C-89B4-72DDF809D78D

Q34673393-0B54A73C-1420-49DD-B136-032E45EECD5D

Q34673393-1716FAA3-A779-4FA4-A47E-73D42178C9D7

Q34673393-1B0BB06A-450C-4888-A80B-2200E1D0DF74

Q34673393-1B4BD1EA-9C36-4AC7-8E7D-5A31A4C6A327

Q34673393-1FFDA350-B72C-4B85-BA04-EEEC9901482D

Q34673393-3105D35F-5DFE-4DD6-BECF-F4AE0404DA24

Q34673393-399160D4-B234-435E-9D21-85F406638C54

Q34673393-464606F0-2AB3-4ED3-BBA4-3717154854D1

Q34673393-4BB3A17A-2C47-428A-AF31-5CF1EBD3CC1E

P304

Q34673393-4F901041-1FD6-459A-911C-E6B190C3F5F5

P31

Q34673393-87420720-8537-4887-BEBB-091EA8222E89

P356

Q34673393-3E026459-D582-40D6-AD97-502CE84BFDC6

P407

Q34673393-3B83F813-09D4-483F-8C47-D25FA035CD82

P433

Q34673393-509BDEB0-3D40-4C4D-8549-E0C98E5EA4C4

P478

Q34673393-178268FB-5C7D-476D-B796-FD1BD6DE1059

P50

Q34673393-137A39CD-755A-4A54-84E2-3402AC9CA6E5

Q34673393-E81277C5-B953-43C5-B190-84C434F9707E

P577

Q34673393-DE4F9A6E-A8E1-4578-955E-123FFABF47C8

P698

Q34673393-65D0E8F9-C269-4D8A-A868-554F2D1887A7

P356

13543784.2015.1095180

P1433

Expert Opinion on Investigational Drugs

P1476

Plazomicin: an investigational therapy for the treatment of urinary tract infections

@en

P2093

Maria Souli

http://www.w3.org/2001/XMLSchema#string

P2860

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials.

Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents.

Synthesis and spectrum of the neoglycoside ACHN-490

Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.

Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates.

Pharmacokinetics and safety of single and multiple doses of ACHN-490 injection administered intravenously in healthy subjects

16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides.

Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece.

P304

1501-1511

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2015.1095180

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Helen Giamarellou

P577

2015-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26419762

http://www.w3.org/2001/XMLSchema#string